INVAInnoviva, Inc.
What is the market doing?
No clear lean: rangebound and heavily shorted.
Rangebound, no clear trend. Price is −2% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How INVA is trading
Innoviva, Inc. is +11% over the past year while the S&P 500 is +18%: 7.8 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −2.2%
vs 200-day average · below trend, but not far
- RSI (14)
- 52
RSI (14) · neutral
- Below its 52-week high
- 13%
Below its 52-week high
Details›
- Last close2026-10-09
- $21.21
- 1 monthS&P 500 +2.7%
- +2.8%
- 1 yearS&P 500 +18%
- +11%
- 5 yearsS&P 500 +88%
- +41%
- vs 50-day average$20.98
- +1.1%
- 52-week high
- $24.24
- 52-week low
- $16.67
- Annualised volatility
- 25%
| Year | Return |
|---|---|
| 2026 (year to date) | +6.1% |
| 2025 | +15% |
| 2024 | +8.2% |
| 2023 | +21% |
| 2022 | −23% |
| 2021 | +39% |
| 2020 | −12% |
| 2019 | −19% |
| 2018 | +23% |
| 2017 | +33% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −0.88% |
| Feb | 10 | 4 of 10 | +2.0% |
| Mar | 10 | 6 of 10 | +0.48% |
| Apr | 10 | 3 of 10 | −1.8% |
| May | 10 | 6 of 10 | +2.5% |
| Jun | 10 | 6 of 10 | +1.2% |
| Jul | 11 | 6 of 11 | +1.7% |
| Aug | 11 | 5 of 11 | −1.9% |
| Sep | 11 | 5 of 11 | −2.2% |
| Oct | 11 | 5 of 11 | +0.31% |
| Nov | 10 | 6 of 10 | +7.2% |
| Dec | 10 | 7 of 10 | +3.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.